Jump to content
Sign in to follow this  
Admin

Fifteen Minute Test May Save 15% or More on Rosacea Treatment

Recommended Posts

rhofade-vs-mirvaso.png

Abstract
Rosacea is a common inflammatory skin condition that impacts a large portion of fair-skinned populations. The redness associated with rosacea can be a significant challenge. Brimonidine sulfate and oxymetazoline HCL were both recently approved by the FDA for the management of facial redness. These agents, however, are costly, and not all patients respond to the medication. Herein, we describe a clinical pearl that helps to optimize patient selection for the medications. This saves the patient and the health care system both time and money. 

Fifteen Minute Test May Save 15% or More on Rosacea Treatment, Journal of Drugs in Dermatology, 2018;17(5):692-693
June 2018 | Volume 17 | Issue 6 | Department | 692 | Copyright © 2018
Evan Darwin BA, Jessica Cervantes BA, and Hadar Lev-Tov MD
University of Miami Miller School of Medicine, Miami, FL

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×